132 related articles for article (PubMed ID: 37344284)
1. Can HDL cholesterol be replaced by paraoxonase 1 activity in the prediction of severe coronary artery disease in patients with type 2 diabetes?
Mahrooz A; Khosravi-Asrami OF; Alizadeh A; Mohmmadi N; Bagheri A; Kashi Z; Bahar A; Nosrati M; Mackness M
Nutr Metab Cardiovasc Dis; 2023 Aug; 33(8):1599-1607. PubMed ID: 37344284
[TBL] [Abstract][Full Text] [Related]
2. Improved risk assessment of coronary artery disease by substituting paraoxonase 1 activity for HDL-C: Novel cardiometabolic biomarkers based on HDL functionality.
Mahrooz A; Shokri Y; Variji A; Zargari M; Alizadeh A; Mehtarian E
Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1166-1176. PubMed ID: 33579580
[TBL] [Abstract][Full Text] [Related]
3. The combined utility of myeloperoxidase (MPO) and paraoxonase 1 (PON1) as two important HDL-associated enzymes in coronary artery disease: Which has a stronger predictive role?
Variji A; Shokri Y; Fallahpour S; Zargari M; Bagheri B; Abediankenari S; Alizadeh A; Mahrooz A
Atherosclerosis; 2019 Jan; 280():7-13. PubMed ID: 30448568
[TBL] [Abstract][Full Text] [Related]
4. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
Göçmen AY; Gümüşlü S; Semiz E
Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.
Singh S; Venketesh S; Verma JS; Verma M; Lellamma CO; Goel RC
Indian J Med Res; 2007 Jun; 125(6):783-7. PubMed ID: 17704557
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K
Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583
[TBL] [Abstract][Full Text] [Related]
7. Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus.
Shen Y; Ding FH; Sun JT; Pu LJ; Zhang RY; Zhang Q; Chen QJ; Shen WF; Lu L
Cardiovasc Diabetol; 2015 May; 14():52. PubMed ID: 25964115
[TBL] [Abstract][Full Text] [Related]
8. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Pereira A; Sousa AC; Freitas S; Ornelas I; Freitas C; Brehm A; Araújo JJ
Rev Port Cardiol; 2010 Apr; 29(4):571-80. PubMed ID: 20734577
[TBL] [Abstract][Full Text] [Related]
9. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
[TBL] [Abstract][Full Text] [Related]
10. Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery disease.
Granér M; James RW; Kahri J; Nieminen MS; Syvänne M; Taskinen MR
J Am Coll Cardiol; 2006 Jun; 47(12):2429-35. PubMed ID: 16781370
[TBL] [Abstract][Full Text] [Related]
11. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
[TBL] [Abstract][Full Text] [Related]
12. Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.
Birjmohun RS; Vergeer M; Stroes ES; Sandhu MS; Ricketts SL; Tanck MW; Wareham NJ; Jukema JW; Kastelein JJ; Khaw KT; Boekholdt SM
PLoS One; 2009 Aug; 4(8):e6809. PubMed ID: 19710913
[TBL] [Abstract][Full Text] [Related]
13. ApoA1/HDL-C ratio as a predictor for coronary artery disease in patients with type 2 diabetes: a matched case-control study.
Ghaemi F; Rabizadeh S; Yadegar A; Mohammadi F; Asadigandomani H; Bafrani MA; Reyhan SK; Esteghamati A; Nakhjavani M
BMC Cardiovasc Disord; 2024 Jun; 24(1):317. PubMed ID: 38914982
[TBL] [Abstract][Full Text] [Related]
14. Low serum paraoxonase1 activity levels predict coronary artery disease severity.
Sun T; Hu J; Yin Z; Xu Z; Zhang L; Fan L; Zhuo Y; Wang C
Oncotarget; 2017 Mar; 8(12):19443-19454. PubMed ID: 28038449
[TBL] [Abstract][Full Text] [Related]
15. Reduced paraoxonase 1 activity as a marker for severe coronary artery disease.
Zhou C; Cao J; Shang L; Tong C; Hu H; Wang H; Fan D; Yu H
Dis Markers; 2013; 35(2):97-103. PubMed ID: 24167353
[TBL] [Abstract][Full Text] [Related]
16. Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.
Ding J; Chen Q; Zhuang X; Feng Z; Xu L; Chen F
Med Sci Monit; 2014 Nov; 20():2421-9. PubMed ID: 25420483
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase-1 (PON1) activity in patients with coronary artery diseases and in diabetic patients.
Amine K; Atouk A; Moussamih S; Saile R; Mikou A; Kettani A
Ann Biol Clin (Paris); 2011; 69(6):671-7. PubMed ID: 22123566
[TBL] [Abstract][Full Text] [Related]
18. Low protective PON1 lactonase activity in an Arab population with high rates of coronary heart disease and diabetes.
Gugliucci A; Caccavello R; Nassar H; Abu Ahmad W; Sinnreich R; Kark JD
Clin Chim Acta; 2015 May; 445():41-7. PubMed ID: 25801214
[TBL] [Abstract][Full Text] [Related]
19. PON1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery disease.
Sharma R; Singh B; Mahajan M
Kaohsiung J Med Sci; 2007 May; 23(5):225-31. PubMed ID: 17525004
[TBL] [Abstract][Full Text] [Related]
20. PON1 M/L55 mutation protects high-risk patients against coronary artery disease.
Oliveira SA; Mansur AP; Ribeiro CC; Ramires JA; Annichino-Bizzacchi JM
Int J Cardiol; 2004 Mar; 94(1):73-7. PubMed ID: 14996478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
